| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,379,584 | 1,552,589 | 1,547,673 | 1,588,086 | | Cost of Revenue | 660,007 | 736,580 | 735,674 | 757,765 | | | Gross Profit | 719,577 | 816,009 | 811,999 | 830,321 | | | Operating Expenses | | Research Development | 46,949 | 49,444 | 53,008 | 53,168 | | Selling General and Administrative | 443,528 | 475,375 | 478,914 | 497,689 | | Non Recurring |
-
| 115,117 | 49,229 | 18,815 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 229,100 | 176,073 | 230,848 | 260,649 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,552 | 12,893 |
-
|
-
| | Earnings Before Interest And Taxes | 230,652 | 188,966 | 230,848 | 260,649 | | Interest Expense | 52,203 | 61,879 | 54,560 | 54,127 | | Income Before Tax | 178,449 | 127,087 | 176,288 | 206,522 | | Income Tax Expense | 72,149 | 29,540 | 69,456 | 70,386 | | Minority Interest |
-
| (4,621) | (6,540) | (4,796) | | | | Net Income From Continuing Ops | 106,300 | 92,926 | 100,292 | 131,340 | | | Non-recurring Events | | Discontinued Operations | 2,623 | (18,974) | (2,063) | (2,831) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 108,923 | 73,952 | 98,229 | 128,509 | | Preferred Stock And Other Adjustments | (4,521) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $104,402 | $73,952 | $98,229 | $128,509 |
|
0.45% Nasdaq 
0.20%
Income Statement
